St. Jude Comprehensive Cancer Center

Comprehensive Cancer Center Leadership

Director

Comprehensive Cancer Center Leadership

Director, Comprehensive Cancer Center
Department of Oncology
Research interest: SWI/SNF (BAF) chromatin remodeling/tumor suppressor


Deputy Director

Comprehensive Cancer Center Leadership

Deputy Director, Comprehensive Cancer Program
Co-Leader, Hematologic Malignancies Program
Department of Pathology
Research interests: genomics, experimental modeling and preclinical therapeutics of acute leukemia


Senior Leadership

Comprehensive Cancer Center Leadership

Associate Director, Basic Research
Co-Leader, Neurobiology and Brain Tumor Program
Department of Developmental Neurobiology
Research interests: PTEN and key signaling pathways in brain tumors


Comprehensive Cancer Center Leadership

Co-Associate Director, Outreach
Director, HPV Cancer Prevention Program
Department of Epidemiology and Cancer Control
Research interests: HPV vaccination; implementation science; partnered and engaged research 


Comprehensive Cancer Center Leadership

Associate Director, Clinical Research
Department of Oncology
Research interests: Clinical trials


Comprehensive Cancer Center Leadership

Associate Director, Population Sciences
Department of Oncology
Research interests: health outcomes after childhood cancer


Comprehensive Cancer Center Leadership

Julie Park, MD


Associate Director, Translational Research
Chair, Department of Oncology
Research interests: neuroblastoma and immuno-oncology


Comprehensive Cancer Center Leadership

Associate Director, Shared Resources
Department of Cell & Molecular Biology
Research interests: genome-editing technologies 


Comprehensive Cancer Center Leadership

Co-Associate Director, Outreach
Department of Global Medicine
Research interests: Global medicine; pediatric solid tumors


photo of Victor Santana

Victor M. Santana, MD

Interim Associate Director, Diversity, Equity & Inclusion
Department of Global Pediatric Medicine & Department of Oncology
Research interests: investigational therapeutics including  innovative treatment for neuroblastoma, research ethics, health dipartites in clinical research and in global research


Comprehensive Cancer Center Leadership

Associate Director, Administration


Comprehensive Cancer Center Leadership

Associate Director, Education and Training
Department of Biochemistry
Research interests: p53 function in tumor suppression and tumorigenesis


Program Leaders

Comprehensive Cancer Center Leadership

Co-Leader, Cancer Control & Survivorship Program
Department of Epidemiology & Cancer Control
Research interests: pediatric neuro-oncology and cancer survivorship


Comprehensive Cancer Center Leadership

Associate Director, Basic Research
Co-Leader, Neurobiology and Brain Tumor Program
Department of Developmental Neurobiology
Research interests: PTEN and key signaling pathways in brain tumors


Comprehensive Cancer Center Leadership

Co-Leader, Developmental Biology and Solid Tumor Program
Department of Developmental Neurobiology
Research interests: retinal development and retinoblastoma


Comprehensive Cancer Center Leadership

Co-Leader, Cancer Biology Program
Department of Immunology
Research interests: apoptosis, autophage and mitochondria


Comprehensive Cancer Center Leadership

Co-Leader, Cancer Biology Program
Department of Structural Biology
Research interests: structural basis of tumor suppressor function


Comprehensive Cancer Center Leadership

Deputy Director, Comprehensive Cancer Program
Co-Leader, Hematologic Malignancies Program
Department of Pathology
Research interests: genomics, experimental modeling and preclinical therapeutics of acute leukemia


Comprehensive Cancer Center Leadership

Co-Leader, Cancer Control & Survivorship Program
Department of Epidemiology and Cancer Control
Research interests: Clinical and population measurement of physical performance and disability


Comprehensive Cancer Center Leadership

Co-Leader, Developmental Biology and Solid Tumor Program
Department of Oncology
Research Interests: Development of novel therapies for pediatric solid tumors with special interest in: pediatric melanoma; soft tissue sarcomas; pediatric gastrointestinal stromal tumors


Comprehensive Cancer Center Leadership

Co-Leader, Hematologic Malignancies Program
Department of Oncology
Research interests: biology and treatment of childhood leukemia


Comprehensive Cancer Center Leadership

Co-Leader, Neurobiology and Brain Tumor Program
Department of Oncology
Research interests: improving survival and reducing treatment-related toxicities for pediatric brain tumors